FFNCX | HBLFX | FFNCX / HBLFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 8 years | - |
Gain YTD | -0.698 | -0.212 | 330% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 2.26B | 11.9B | 19% |
Annual Yield % from dividends | 1.43 | 3.67 | 39% |
Returns for 1 year | 5.75 | 3.14 | 183% |
Returns for 3 years | -1.84 | -1.34 | 138% |
Returns for 5 years | 11.58 | 8.22 | 141% |
Returns for 10 years | 28.39 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DEUS | 54.15 | 0.46 | +0.86% |
Xtrackers Russell US Multifactor ETF | |||
RSEE | 28.10 | 0.07 | +0.24% |
Rareview Systematic Equity ETF | |||
CGUS | 34.80 | 0.03 | +0.09% |
Capital Group Core Equity ETF | |||
VTES | 100.03 | -0.14 | -0.14% |
Vanguard Short-Term Tax-Exmpt Bd ETF | |||
CNCR | 11.42 | -0.33 | -2.85% |
Range Cancer Therapeutics ETF |